These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
416 related items for PubMed ID: 29705704
1. FOXM1 promotes proliferation in human hepatocellular carcinoma cells by transcriptional activation of CCNB1. Chai N, Xie HH, Yin JP, Sa KD, Guo Y, Wang M, Liu J, Zhang XF, Zhang X, Yin H, Nie YZ, Wu KC, Yang AG, Zhang R. Biochem Biophys Res Commun; 2018 Jun 12; 500(4):924-929. PubMed ID: 29705704 [Abstract] [Full Text] [Related]
2. LXRα-mediated downregulation of FOXM1 suppresses the proliferation of hepatocellular carcinoma cells. Hu C, Liu D, Zhang Y, Lou G, Huang G, Chen B, Shen X, Gao M, Gong W, Zhou P, Dai S, Zeng Y, He F. Oncogene; 2014 May 29; 33(22):2888-97. PubMed ID: 23812424 [Abstract] [Full Text] [Related]
3. The CCCTC-binding factor (CTCF)-forkhead box protein M1 axis regulates tumour growth and metastasis in hepatocellular carcinoma. Zhang B, Zhang Y, Zou X, Chan AW, Zhang R, Lee TK, Liu H, Lau EY, Ho NP, Lai PB, Cheung YS, To KF, Wong HK, Choy KW, Keng VW, Chow LM, Chan KK, Cheng AS, Ko BC. J Pathol; 2017 Dec 29; 243(4):418-430. PubMed ID: 28862757 [Abstract] [Full Text] [Related]
4. Downreguation of FoxM1 by miR-214 inhibits proliferation and migration in hepatocellular carcinoma. Tian C, Wu H, Li C, Tian X, Sun Y, Liu E, Liao X, Song W. Gene Ther; 2018 Jul 29; 25(4):312-319. PubMed ID: 29973656 [Abstract] [Full Text] [Related]
5. FOXM1 regulates glycolysis in hepatocellular carcinoma by transactivating glucose transporter 1 expression. Shang R, Pu M, Li Y, Wang D. Oncol Rep; 2017 Apr 29; 37(4):2261-2269. PubMed ID: 28260073 [Abstract] [Full Text] [Related]
6. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma. Meng FD, Wei JC, Qu K, Wang ZX, Wu QF, Tai MH, Liu HC, Zhang RY, Liu C. World J Gastroenterol; 2015 Jan 07; 21(1):196-213. PubMed ID: 25574092 [Abstract] [Full Text] [Related]
7. Peroxiredoxin II promotes hepatic tumorigenesis through cooperation with Ras/Forkhead box M1 signaling pathway. Park YH, Kim SU, Kwon TH, Kim JM, Song IS, Shin HJ, Lee BK, Bang DH, Lee SJ, Lee DS, Chang KT, Kim BY, Yu DY. Oncogene; 2016 Jul 07; 35(27):3503-13. PubMed ID: 26500057 [Abstract] [Full Text] [Related]
8. The TNF-α/ROS/HIF-1-induced upregulation of FoxMI expression promotes HCC proliferation and resistance to apoptosis. Xia L, Mo P, Huang W, Zhang L, Wang Y, Zhu H, Tian D, Liu J, Chen Z, Zhang Y, Chen Z, Hu H, Fan D, Nie Y, Wu K. Carcinogenesis; 2012 Nov 07; 33(11):2250-9. PubMed ID: 22831955 [Abstract] [Full Text] [Related]
9. FOXM1 promotes hepatocellular carcinoma progression by regulating KIF4A expression. Hu G, Yan Z, Zhang C, Cheng M, Yan Y, Wang Y, Deng L, Lu Q, Luo S. J Exp Clin Cancer Res; 2019 May 09; 38(1):188. PubMed ID: 31072351 [Abstract] [Full Text] [Related]
10. Elevated expression of FoxM1 promotes the tumor cell proliferation in hepatocellular carcinoma. Yu M, Tang Z, Meng F, Tai M, Zhang J, Wang R, Liu C, Wu Q. Tumour Biol; 2016 Jan 09; 37(1):1289-97. PubMed ID: 26289845 [Abstract] [Full Text] [Related]
11. The critical role of dysregulated Hh-FOXM1-TPX2 signaling in human hepatocellular carcinoma cell proliferation. Wang Y, Wang H, Yan Z, Li G, Hu G, Zhang H, Huang D, Wang Y, Zhang X, Yan Y, Lu Q, Cheng M, Luo S. Cell Commun Signal; 2020 Jul 28; 18(1):116. PubMed ID: 32723329 [Abstract] [Full Text] [Related]
12. Induction of Chromosome Instability by Activation of Yes-Associated Protein and Forkhead Box M1 in Liver Cancer. Weiler SME, Pinna F, Wolf T, Lutz T, Geldiyev A, Sticht C, Knaub M, Thomann S, Bissinger M, Wan S, Rössler S, Becker D, Gretz N, Lang H, Bergmann F, Ustiyan V, Kalin TV, Singer S, Lee JS, Marquardt JU, Schirmacher P, Kalinichenko VV, Breuhahn K. Gastroenterology; 2017 Jun 28; 152(8):2037-2051.e22. PubMed ID: 28249813 [Abstract] [Full Text] [Related]
13. Aberrant activation of hedgehog signaling promotes cell proliferation via the transcriptional activation of forkhead Box M1 in colorectal cancer cells. Wang D, Hu G, Du Y, Zhang C, Lu Q, Lv N, Luo S. J Exp Clin Cancer Res; 2017 Feb 02; 36(1):23. PubMed ID: 28148279 [Abstract] [Full Text] [Related]
14. MicroRNA-216b is downregulated in hepatocellular carcinoma and inhibits HepG2 cell growth by targeting Forkhead box protein M1. Zheng WW, Zhou J, Zhang CH, Liu XS. Eur Rev Med Pharmacol Sci; 2016 Jun 02; 20(12):2541-50. PubMed ID: 27383303 [Abstract] [Full Text] [Related]
15. Inhibition of CIP2A attenuates tumor progression by inducing cell cycle arrest and promoting cellular senescence in hepatocellular carcinoma. Yang X, Qu K, Tao J, Yin G, Han S, Liu Q, Sun H. Biochem Biophys Res Commun; 2018 Jan 08; 495(2):1807-1814. PubMed ID: 29175329 [Abstract] [Full Text] [Related]
16. Upregulated FoxM1 expression induced by hepatitis B virus X protein promotes tumor metastasis and indicates poor prognosis in hepatitis B virus-related hepatocellular carcinoma. Xia L, Huang W, Tian D, Zhu H, Zhang Y, Hu H, Fan D, Nie Y, Wu K. J Hepatol; 2012 Sep 08; 57(3):600-12. PubMed ID: 22613004 [Abstract] [Full Text] [Related]
17. Essential roles of FoxM1 in Ras-induced liver cancer progression and in cancer cells with stem cell features. Kopanja D, Pandey A, Kiefer M, Wang Z, Chandan N, Carr JR, Franks R, Yu DY, Guzman G, Maker A, Raychaudhuri P. J Hepatol; 2015 Aug 08; 63(2):429-36. PubMed ID: 25828473 [Abstract] [Full Text] [Related]
18. A gene expression signature of FOXM1 predicts the prognosis of hepatocellular carcinoma. Song BN, Chu IS. Exp Mol Med; 2018 Jan 05; 50(1):e418. PubMed ID: 29303511 [Abstract] [Full Text] [Related]
19. Thyroid hormones suppress FOXM1 expression to reduce liver cancer progression. Wu CH, Yeh CT, Lin KH. Oncol Rep; 2020 Oct 05; 44(4):1686-1698. PubMed ID: 32945493 [Abstract] [Full Text] [Related]
20. Forkhead box M1B is a determinant of rat susceptibility to hepatocarcinogenesis and sustains ERK activity in human HCC. Calvisi DF, Pinna F, Ladu S, Pellegrino R, Simile MM, Frau M, De Miglio MR, Tomasi ML, Sanna V, Muroni MR, Feo F, Pascale RM. Gut; 2009 May 05; 58(5):679-87. PubMed ID: 19136513 [Abstract] [Full Text] [Related] Page: [Next] [New Search]